Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.25x is 97% above its 3-year average of -9.50x, near the high end of its 3-year range (-22.81x–-0.25x).
96.59% above its 12-month average of -7.32x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-12-31): -3.10x.
INTEREST COVERAGE RATIO
-0.25x
INTEREST COVERAGE RATIO AVG TTM
-7.32x
INTEREST COVERAGE RATIO AVG 3Y
-9.50x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+96.59%
CURRENT VS 3Y AVG
+97.37%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.85x
median of 397 covered companies
CURRENT VS SECTOR MEDIAN
+94.85%
vs the sector median at left
Moolec Science S.A.
Market Cap
$3.40M
Interest Coverage Ratio
-0.25x
TTM Avg
-7.32x
3Y Avg
-9.50x
5Y Avg
N/A
Market Cap
$3.49M
Interest Coverage Ratio
N/A
TTM Avg
3249.00x
3Y Avg
3249.00x
5Y Avg
3249.00x
Market Cap
$3.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.27M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.40M | -0.25x | -7.32x | -9.50x | N/A |
| Evogene Ltd. (EVGN)vs › | $3.46M | -7.42x | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A | 3249.00x | 3249.00x | 3249.00x |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | N/A | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -507.49x | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.28M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | N/A | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | -12.83x | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.00M | -345.15x | 1.19x | 1.19x | 1.19x |
Interest Coverage
-0.3x
Debt/Equity
7.21
Current Ratio
0.15
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -3.10x |
| 2024-09-30 | -3.82x |
| 2024-06-30 | -4.82x |
| 2024-03-31 | -5.69x |
| 2023-12-31 | -19.18x |
| 2023-09-30 | -22.81x |
| 2022-12-31 | -15.77x |
| 2022-03-31 | -0.80x |
